Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Plos One|August 23, 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ TumorsRadhika Thokala, Simon Olivares, Tiejuan Mi, et al.
Cancer Research|April 29, 2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignanciesJeff K Davies, Harjeet Singh, Helen Huls, et al.
Human Gene Therapy|November 24, 2011
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignanciesPartow Kebriaei, Helen Huls, Bipulendu Jena, et al.
Journal of Immunological Methods|July 1, 2005
A quantitative high-throughput chemotaxis assay using bioluminescent reporter cellsReena P Vishwanath, Christine E Brown, Jamie R Wagner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromesZhuang Zuo, Sourindra Maiti, Shimin Hu, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 5, 2012
Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64Parijat Bhatnagar, Zheng Li, Yoonsu Choi, et al.
Blood|October 28, 2004
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1Laurence J N Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, et al.
Journal of Pediatric Hematology/Oncology|September 1, 2017
Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young AdultsOssama M Maher, Jorge G Silva, Winston W Huh, et al.
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Blood|October 24, 2002
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effectLaurence J N Cooper, Max S Topp, Lisa Marie Serrano, et al.
Pageof 15